Published in Retrovirology on November 17, 2009
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology (2012) 1.16
HTLV-1 Rex: the courier of viral messages making use of the host vehicle. Front Microbiol (2012) 0.93
Human T-lymphotropic virus proteins and post-translational modification pathways. World J Virol (2012) 0.79
Identification and characterization of HTLV-1 HBZ post-translational modifications. PLoS One (2014) 0.78
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms. Retrovirology (2015) 0.77
HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication. Viruses (2016) 0.75
Is unphosphorylated Rex, as multifunctional protein of HTLV-1, a fully intrinsically disordered protein? An in silico study. Biochem Biophys Rep (2016) 0.75
Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell (1989) 7.46
The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science (1985) 6.60
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol (2007) 4.49
Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc Natl Acad Sci U S A (1987) 4.10
Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell (1988) 3.92
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A (2005) 2.86
Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49
Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol (1991) 2.41
Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr Opin Chem Biol (2001) 2.22
Ribonuclease S-peptide as a carrier in fusion proteins. Protein Sci (1993) 2.04
The HTLV-1 Tax interactome. Retrovirology (2008) 2.02
Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol (1999) 1.94
ABRF-PRG03: phosphorylation site determination. J Biomol Tech (2003) 1.83
Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature (1989) 1.77
Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology (2005) 1.70
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc Natl Acad Sci U S A (1991) 1.68
Post-translational modifications influence transcription factor activity: a view from the ETS superfamily. Bioessays (2005) 1.67
Chronic neurodegenerative disease associated with HTLV-II infection. Lancet (1992) 1.58
The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol (1996) 1.50
Mapping of phosphorylation sites of gel-isolated proteins by nanoelectrospray tandem mass spectrometry: potentials and limitations. Anal Chem (1999) 1.49
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology (1990) 1.48
Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity. J Virol (1991) 1.48
Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J Virol (1993) 1.45
Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation. J Biol Chem (2007) 1.43
Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol (1998) 1.43
The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal. J Virol (1996) 1.42
Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. J Virol (1992) 1.40
Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene (2005) 1.32
Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol (1998) 1.31
Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol (1991) 1.28
Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs. J Virol (1999) 1.26
Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells. J Virol (2000) 1.24
Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev (1997) 1.22
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology (2009) 1.16
HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood (2003) 1.15
The human T-cell leukemia virus Rex protein. Front Biosci (2005) 1.14
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J Virol (1997) 1.14
Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. J Virol (1998) 1.13
Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2. J Virol (2003) 1.10
The peptidyl-prolyl isomerase Pin1. Prog Cell Cycle Res (2003) 1.08
Mutational analysis of human T-cell leukemia virus type 2 Tax. J Virol (1997) 1.06
Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review. Mol Cell Proteomics (2005) 1.05
Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J Biol Chem (2006) 1.05
Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein. J Virol (1992) 1.02
Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product. J Virol (1991) 0.97
Phosphorylation of the Rex protein of human T-cell leukemia virus type I. J Biol Chem (1992) 0.96
The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level. Front Biosci (2005) 0.95
The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation. J Virol (1991) 0.95
Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol (1993) 0.95
Functional domain structure of human T-cell leukemia virus type 2 rex. J Virol (2003) 0.94
Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function. Virology (1993) 0.93
Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-I). Biochem Biophys Res Commun (1990) 0.92
Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J Virol (2001) 0.89
Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome. Retrovirology (2008) 0.89
Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology (1991) 0.84
HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection. N Engl J Med (2000) 0.81
Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication. J Virol (2009) 0.79
Site-specific phosphorylation regulates human T-cell leukemia virus type 2 Rex function in vivo. J Virol (2009) 0.79
Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res (2002) 7.11
Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina). Nat Biotechnol (2008) 5.38
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. Clin Chem (2004) 3.28
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem (2002) 3.05
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet (2013) 2.87
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reesei. J Biol Chem (2003) 2.77
Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia. BMJ Qual Saf (2013) 2.47
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet (2010) 2.44
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood (2006) 1.98
Swollenin, a Trichoderma reesei protein with sequence similarity to the plant expansins, exhibits disruption activity on cellulosic materials. Eur J Biochem (2002) 1.97
Smart pipes--instrumented water pipes, can this be made a reality? Sensors (Basel) (2011) 1.73
Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene (2005) 1.73
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood (2008) 1.63
Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol (2004) 1.63
Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res (2009) 1.60
Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int (2006) 1.59
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis. Cancer Inform (2005) 1.58
Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1. J Virol (2013) 1.58
Public reporting of hospital outcomes based on administrative data: risks and opportunities. Med J Aust (2006) 1.56
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics (2006) 1.56
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology (2005) 1.55
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog (2011) 1.53
Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res (2002) 1.51
Tissue imaging using nanospray desorption electrospray ionization mass spectrometry. Anal Chem (2011) 1.50
Compliance with Surgical Care Improvement Project measures and hospital-associated infections following hip arthroplasty. J Bone Joint Surg Am (2012) 1.50
BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci U S A (2013) 1.47
The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology (2009) 1.43
Multisite, quality-improvement collaboration to optimise cardiac care in Queensland public hospitals. Med J Aust (2004) 1.37
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol (2004) 1.34
Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J Biol Chem (2003) 1.33
A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer (2003) 1.33
The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol (2005) 1.33
Computational protein biomarker prediction: a case study for prostate cancer. BMC Bioinformatics (2004) 1.31
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. Clin Chem (2008) 1.31
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis (2008) 1.30
Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res (2005) 1.30
Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg (2004) 1.28
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers. J Clin Psychiatry (2014) 1.25
Enzymatic properties and intracellular localization of the novel Trichoderma reesei beta-glucosidase BGLII (cel1A). Appl Environ Microbiol (2002) 1.25
MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol (2006) 1.22
PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood (2005) 1.19
Serum protein profiles to identify head and neck cancer. Clin Cancer Res (2004) 1.18
Sleep monitoring in the intensive care unit: comparison of nurse assessment, actigraphy and polysomnography. Intensive Care Med (2008) 1.18
HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase. J Biol Chem (2008) 1.18
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Dis Markers (2004) 1.18
A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J Biol Chem (2003) 1.16
HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood (2003) 1.15
Intergroup communication between hospital doctors: implications for quality of patient care. Soc Sci Med (2009) 1.15
Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol (2009) 1.14
Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J Virol Methods (2007) 1.14
The human T-cell leukemia virus Rex protein. Front Biosci (2005) 1.14
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. J Proteome Res (2009) 1.13
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis. Viruses (2010) 1.13
Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer (2004) 1.12
A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion (2013) 1.12
Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope (2008) 1.10
Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2. J Virol (2003) 1.10
Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics (2011) 1.09
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics (2012) 1.08
Retrotransposition-Competent Human LINE-1 Induces Apoptosis in Cancer Cells With Intact p53. J Biomed Biotechnol (2004) 1.08
Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst (2003) 1.08
Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics (2004) 1.06
HIV prevention with jail and prison inmates: Maryland's Prevention Case Management program. AIDS Educ Prev (2003) 1.06
RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucleic Acids Res (2007) 1.06
Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J Biol Chem (2006) 1.05
Interaction domains of the UL16 and UL21 tegument proteins of herpes simplex virus. J Virol (2009) 1.04
The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax. Blood (2011) 1.04
SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers (2004) 1.03
Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. J Proteomics (2009) 1.03
Improvement of foreign-protein production in Aspergillus niger var. awamori by constitutive induction of the unfolded-protein response. Appl Environ Microbiol (2003) 1.03
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J Virol (2006) 1.02
Neuronal migration and molecular conservation with leukocyte chemotaxis. Genes Dev (2002) 1.02
Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg (2009) 1.01
The LIM protein Ajuba regulates phosphatidylinositol 4,5-bisphosphate levels in migrating cells through an interaction with and activation of PIPKI alpha. Mol Cell Biol (2005) 1.01
Human T-cell leukemia virus type 1 Tax oncoprotein prevents DNA damage-induced chromatin egress of hyperphosphorylated Chk2. J Biol Chem (2007) 1.00
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator. Blood (2011) 0.99
The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells. Virology (2003) 0.99
MALDI tissue imaging: from biomarker discovery to clinical applications. Anal Bioanal Chem (2011) 0.98
In-depth proteomic analyses of direct expressed prostatic secretions. J Proteome Res (2010) 0.97
Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet (2011) 0.97
Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol (2005) 0.97
Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res (2012) 0.97
Transformation studies with a human T-cell leukemia virus type 1 molecular clone. J Virol Methods (2004) 0.96
Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling. Rapid Commun Mass Spectrom (2006) 0.96
Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol (2012) 0.96
Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy. J Virol (2013) 0.95
Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg (2007) 0.95
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology. Urol Oncol (2004) 0.95
Signal detection in high-resolution mass spectrometry data. J Proteome Res (2008) 0.95